Summary:
A clinical trial of an mRNA vaccine for Epstein-Barr Virus (EBV). The Eclipse Trial is researching an investigational vaccine to protect against EBV and infectious mononucleosis (mono), and you may be able to take part.
Qualified participants must:
- Be 18 years to 30 years old
- Be generally healthy
- Additional criteria may apply
Qualified Participants May Receive:
Qualified participants will receive all study related test and procedures at no cost. There is no charge to participate. No insurance or copay is required. Compensation may be provided for time and travel.